Hypophosphatemia Causes and Diagnostic Considerations

Primary Mechanisms

X-linked hypophosphatemia (XLH) accounts for approximately 80% of genetic hypophosphatemic disorders, characterized by elevated or inappropriately normal FGF23 levels despite hypophosphatemia 1, 2
Ferric carboxymaltose (FCM) causes hypophosphatemia in 47-75% of patients through FGF23-mediated hyperphosphaturia, creating the "6H-syndrome" (high FGF23, hyperphosphaturia, hypophosphatemia, hypovitaminosis D, hypocalcemia, secondary hyperparathyroidism) 3, 4
Fanconi syndrome causes generalized proximal tubular dysfunction with phosphate, amino acid, glucose, and protein wasting 1, 2
Tumor-induced osteomalacia produces ectopic FGF23 secretion 2
Cystinosis leads to cysteine accumulation in proximal tubules 5, 6
Dent disease (CLCN5 mutations) and hereditary hypophosphatemic rickets with hypercalciuria (SLC34A3 mutations) 5, 6
Iatrogenic proximal tubulopathy from drug toxicity 5, 6

Malabsorptive disorders including inflammatory bowel disease, celiac disease, and bariatric surgery reduce phosphate absorption 4
Post-kidney transplant patients experience reduced intestinal phosphorus absorption 4

Kidney replacement therapy (KRT) causes hypophosphatemia in 60-80% of ICU patients, rising to 80% during prolonged continuous renal replacement therapy (CRRT) 7, 4
Diuretics precipitate hypophosphatemia through urinary losses 7
Immunosuppressive drugs, particularly post-transplant, cause hypophosphatemia in 5% of kidney transplant patients at 1 year 4
Diarrhea contributes through intestinal losses 7

Persistent hypophosphatemia can cause osteomalacia, fractures, rhabdomyolysis, cardiac arrhythmias, respiratory failure, and neurological complications 4
FCM-induced hypophosphatemia can persist up to 6 months and cause osteomalacia with repeated use—avoid in patients with recurrent blood loss or malabsorptive disorders 3, 4
Always exclude metabolic acidosis, hypercalciuria, and generalized Fanconi syndrome by measuring serum bicarbonate and urinary calcium, amino acids, glucose, and low-molecular-weight proteins 1

Geriatric patients face compounded risk due to progressive muscle mass loss and osteoporosis, combined with higher rates of malnutrition and polypharmacy, according to Clinical Nutrition guidelines 8
Severely malnourished older subjects require stepwise substrate increases with strict electrolyte monitoring to prevent refeeding syndrome, as recommended by Clinical Nutrition 8

Refeeding syndrome is a critical cause of hypophosphatemia, particularly in malnourished elderly patients, where glucose infusion triggers acute insulin release that drives phosphate intracellularly, as reported in Clinical Nutrition 8
Parenteral nutrition, especially glucose-containing solutions, can provoke rapid drops in plasma phosphate, leading to acute psychotic changes and delirium in geriatric patients, according to Clinical Nutrition 8

Glucose infusion can cause acute water and sodium retention through sudden insulin increase, compounding electrolyte disturbances in geriatric patients, as noted in Clinical Nutrition 8
Thiamine deficiency can be evoked during refeeding syndrome, causing Wernicke's or Korsakoff's syndromes with diplopia, confabulation, confusion, and coma, as reported in Clinical Nutrition 8